Halda Therapeutics
Biotechnology, 115 Munson St, New Haven, Connecticut, 06511, United States, 11-50 Employees
Phone Number: 47********
Who is HALDA THERAPEUTICS
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTACTM therapeutics, a new drug modality for the treatment of cancer. Founded by world renowne...
Read More
-
Headquarters: 115 Munson St, New Haven, Connecticut, 06511, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8093
|
NAICS Code: 621399 |
Show More
Does something look wrong? Fix it. | View contact records from HALDA THERAPEUTICS
Halda Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Halda Therapeutics
Answer: Halda Therapeutics's headquarters are located at 115 Munson St, New Haven, Connecticut, 06511, United States
Answer: Halda Therapeutics's phone number is 47********
Answer: Halda Therapeutics's official website is https://haldatherapeutics.com
Answer: Halda Therapeutics's revenue is $250 Million to $500 Million
Answer: Halda Therapeutics's SIC: 8093
Answer: Halda Therapeutics's NAICS: 621399
Answer: Halda Therapeutics has 11-50 employees
Answer: Halda Therapeutics is in Biotechnology
Answer: Halda Therapeutics contact info: Phone number: 47******** Website: https://haldatherapeutics.com
Answer: Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTACTM therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic disease drivers to target cancer. This powerful technology is designed to overcome the known bypass mechanisms of drug resistance, a common limitation of todays precision cancer medicines. Using a novel hold and kill mechanism, RIPTAC therapeutics target cancer cells selectively by bringing two proteins together in a tightly regulated manner, causing the loss of an essential function for cell survival and subsequent cancer cell death. We have built a pipeline of RIPTAC therapeutics for major cancer types, uniquely addressing the unmet needs of drug resistant cancer patients, and we will continue to invent new medicines using our proprietary platform technology. We are a bold company where collaboration, passion, and creativity thrive, all of which allows us to push the boundaries of drug discovery to identify better solutions. Halda is proud to be a New Haven, CT based biotech, located with headquarters and state-of-the-art labs in Science Park.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month